Diabetes 51:1166-1171, 2002
© 2002 by the American Diabetes Association, Inc.
Overexpression of the Sarcoplasmic Reticulum Ca2+-ATPase Improves Myocardial Contractility in Diabetic Cardiomyopathy
Susanne U. Trost,
Darrell D. Belke,
Wolfgang F. Bluhm,
Markus Meyer,
Eric Swanson, and
Wolfgang H. Dillmann
From the Department of Medicine, University of California, San Diego, California
Diabetic cardiomyopathy is characterized by reduced cardiac contractility due to direct changes in heart muscle function independent of vascular disease. An important contributor to contractile dysfunction in the diabetic state is an impaired sarcoplasmic reticulum (SR) function, leading to disturbed intracellular calcium handling. We investigated whether overexpression of the SR calcium pump (SERCA2a) in transgenic mice could reduce the impact of diabetes on the development of cardiomyopathy. Diabetes was induced by streptozotocin injection (200 mg/kg), and left ventricular (LV) function was analyzed in isolated hearts 3 weeks later. In diabetic hearts systolic LV pressure was decreased by 15% and maximum speed of relaxation (-dP/dt) by 34%. Functional changes were also assessed in isolated papillary muscles. Active force was reduced by 61% and maximum speed of relaxation by 65% in the diabetic state. The contractile impairment was accompanied by a 30% decrease in SERCA2a protein in diabetic mice. We investigated whether increased SERCA2a expression in transgenic SERCA2a-overexpressing mice could compensate for the diabetes-induced decrease in cardiac function. Under normal conditions, SERCA2a overexpressors show improved contractile performance relative to wild-type (WT) mice (-dP/dt: 3,169 vs. 2,559 mmHg/s, respectively). Measurement of LV function in hearts from diabetic SERCA2a mice revealed systolic and diastolic functions that were similar to WT control mice and markedly improved relative to diabetic WT mice (-dP/dt: 2,534 vs. 1,690 mmHg/s in diabetic SERCA2a vs. diabetic WT mice, respectively). Similarly, the contractile behavior of isolated papillary muscles from diabetic SERCA2a mice was not different from that of control mice. SERCA2a protein expression was higher (60%) in diabetic SERCA2a mice than WT diabetic mice. These results indicate that overexpression of SERCA2a can protect diabetic hearts from severe contractile dysfunction, presumably by improving the calcium sequestration of the SR.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. A. Lacombe, S. Viatchenko-Karpinski, D. Terentyev, A. Sridhar, S. Emani, J. D. Bonagura, D. S. Feldman, S. Gyorke, and C. A. Carnes
Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2007;
293(5):
R1787 - R1797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Boudina and E. D. Abel
Diabetic Cardiomyopathy Revisited
Circulation,
June 26, 2007;
115(25):
3213 - 3223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Belke, B. Gloss, E. A. Swanson, and W. H. Dillmann
Adeno-Associated Virus-Mediated Expression of Thyroid Hormone Receptor Isoforms-{alpha}1 and -{beta}1 Improves Contractile Function in Pressure Overload-Induced Cardiac Hypertrophy
Endocrinology,
June 1, 2007;
148(6):
2870 - 2877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Belke, E. Swanson, J. Suarez, B. T. Scott, A. E. Stenbit, and W. H. Dillmann
Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucose
Am J Physiol Heart Circ Physiol,
April 1, 2007;
292(4):
H1755 - H1763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Westermann, S. Rutschow, S. Jager, A. Linderer, S. Anker, A. Riad, T. Unger, H.-P. Schultheiss, M. Pauschinger, and C. Tschope
Contributions of Inflammation and Cardiac Matrix Metalloproteinase Activity to Cardiac Failure in Diabetic Cardiomyopathy: The Role of Angiotensin Type 1 Receptor Antagonism
Diabetes,
March 1, 2007;
56(3):
641 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Gerber, B. J. Aronow, and M. A. Matlib
Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts
Am J Physiol Cell Physiol,
December 1, 2006;
291(6):
C1198 - C1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pozo-Navas, H. Stessel, G. Wolkart, and F. Brunner
Role of Myocardial Nitric Oxide in Diabetic Ischemia-Reperfusion Dysfunction: Studies in Mice with Myocyte-Specific Overexpression of Endothelial Nitric-Oxide Synthase
J. Pharmacol. Exp. Ther.,
November 1, 2006;
319(2):
729 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Vasanji, E. J. F. Cantor, D. Juric, M. Moyen, and T. Netticadan
Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance
Am J Physiol Cell Physiol,
October 1, 2006;
291(4):
C772 - C780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol,
October 1, 2006;
291(4):
H1489 - H1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-K. Kim, J. Suarez, Y. Hu, P. M. McDonough, C. Boer, D. J. Dix, and W. H. Dillmann
Deletion of the Inducible 70-kDa Heat Shock Protein Genes in Mice Impairs Cardiac Contractile Function and Calcium Handling Associated With Hypertrophy
Circulation,
June 6, 2006;
113(22):
2589 - 2597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Li, C. X Fang, N. S Aberle II, B. H Ren, A. F Ceylan-Isik, and J. Ren
Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function
J. Endocrinol.,
September 1, 2005;
186(3):
491 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Panagia, G. F. Gibbons, G. K. Radda, and K. Clarke
PPAR-{alpha} activation required for decreased glucose uptake and increased susceptibility to injury during ischemia
Am J Physiol Heart Circ Physiol,
June 1, 2005;
288(6):
H2677 - H2683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hu, D. Belke, J. Suarez, E. Swanson, R. Clark, M. Hoshijima, and W. H. Dillmann
Adenovirus-Mediated Overexpression of O-GlcNAcase Improves Contractile Function in the Diabetic Heart
Circ. Res.,
May 13, 2005;
96(9):
1006 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Jeong, K. Kinugawa, C. Vinson, and C. S. Long
AFos Dissociates Cardiac Myocyte Hypertrophy and Expression of the Pathological Gene Program
Circulation,
April 5, 2005;
111(13):
1645 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Chen, Y.-X. Shan, T.-L. Yang, H.-D. Lin, J.-W. Chen, S.-J. Lin, and P. H. Wang
Insulin Deficiency Downregulated Heat Shock Protein 60 and IGF-1 Receptor Signaling in Diabetic Myocardium
Diabetes,
January 1, 2005;
54(1):
175 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Belke, E. A. Swanson, and W. H. Dillmann
Decreased Sarcoplasmic Reticulum Activity and Contractility in Diabetic db/db Mouse Heart
Diabetes,
December 1, 2004;
53(12):
3201 - 3208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Y. Fang, J. B. Prins, and T. H. Marwick
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Endocr. Rev.,
August 1, 2004;
25(4):
543 - 567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Bidasee, Y. Zhang, C. H. Shao, M. Wang, K. P. Patel, U. D. Dincer, and H. R. Besch
Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase
Diabetes,
February 1, 2004;
53(2):
463 - 473.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. W. Dorn II and J. D. Molkentin
Manipulating Cardiac Contractility in Heart Failure: Data From Mice and Men
Circulation,
January 20, 2004;
109(2):
150 - 158.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Suarez, D. D. Belke, B. Gloss, T. Dieterle, P. M. McDonough, Y.-K. Kim, L. L. Brunton, and W. H. Dillmann
In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol,
January 1, 2004;
286(1):
H68 - H75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Clark, P. M. McDonough, E. Swanson, S. U. Trost, M. Suzuki, M. Fukuda, and W. H. Dillmann
Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation
J. Biol. Chem.,
November 7, 2003;
278(45):
44230 - 44237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chaudhri, F. del Monte, R. J. Hajjar, and S. E. Harding
Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes
Am J Physiol Heart Circ Physiol,
December 1, 2002;
283(6):
H2450 - H2457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Choi, Y. Zhong, B. D. Hoit, I. L. Grupp, H. Hahn, K. W. Dilly, S. Guatimosim, W. J. Lederer, and M. A. Matlib
Defective intracellular Ca2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats
Am J Physiol Heart Circ Physiol,
October 1, 2002;
283(4):
H1398 - H1408.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|